Hepatocellular carcinoma and hepatitis C in Mexico

Hepato-Gastroenterology

Volumn 52, Issue 64, 2005, Pages 1159-1162

  Mondragón Sánchez, Ricardo ^a,b   Garduño López, Ana Lilia ^a   Hernández Castillo, Eduardo ^a   Gómez Gómez, Elvira ^a   Ruiz Molina, Juan M ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b NONE   (Mexico)

Author keywords

Hepatitis C; Hepatocellular carcinoma

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; TAMOXIFEN; THALIDOMIDE;

ALCOHOL ABUSE; CANCER SURVIVAL; DISEASE ASSOCIATION; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MEXICO; PALLIATIVE THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; INCIDENCE; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MEXICO; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 21944443277     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Mitra A: Hepatitis C-related hepatocellular carcinoma: prevalence around the world, factors interacting, and role of genotypes. Epidemiol Rev 1999; 21:180-187.
2. Linsell DA, Hibbinson H: The geographic pathology of liver cell cancer. In: Cameron HM, Linsell DA, Warwick GP (Eds.). Liver cell cancer. New York: Elsevier, 1976; pp. 1-16.
3. Beasley RP: Hepatitis B virus as the etiologic agent in hepatocellular carcinoma epidemiologic considerations. Hepatology 1982; 2(Suppl):21-26.
4. London WT: Primary hepatocellular carcinoma. Etiology, pathogenesis and prevention. Hum Pathol 1981; 12:1085-1097.
5. Registro Histopatológico de Neoplasias en México: Secretaria de Salud y Asistencia 1993-1996.
6. Cortes-Espinosa T, Mondragón-Sánchez R, Hurtado-Andrade H, Sánchez-Cisneros R: Hepatocellular Carcinoma and Hepatic Cirrhosis in Mexico: A 25 year Necroscopy Review. Hepatogastroenterology 1997; 44:1401-1403.
7. Tanaka K, Hirohata T, Koga S, et al: Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991; 67:429-433.
8. Resnick RH, Koff R: Hepatitis C-related hepatocellular carcinoma, prevalence and significance. Arch Intern Med 1993; 153:1672-1677.
9. Adler M, Goubau P, Nevens F, Van Vlierberghe H: Hepatitis C virus: the burden of the disease. Acta Gastroenterol Belg 2002; 65:83-86.
10. Degos F, Christidis C, Ganne-Carrie N, Farmachidi J, Degott C, Guettier C, Trinchet J, et al: Hepatitis C virus related cirrhosis: time to occurrence of Hepatocellular Carcinoma and death. Gut 2000: 47:131-136.
11. Fattovich G, Giustina G, Degos F, et al: Morbidity and mortality in compensated cirrhosis type C: A retrospective follow up study of 384 patients. Gastroenterology 1997; 112:463.
12. Okuda K: Hepatocellular Carcinoma. J Hepatol 2000; 32(1 Suppl):225-237.
13. Okuda K, Ohtsuki T, Obata H, et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985; 56:918-928.
14. Fleming ID, Cooper JS, Henson DE, et al: AJCC Cancer Staging Manual. 1997.
15. Wantz GE, Payne MA: Experience with portocaval shunt for portal hypertension N Engl J Med 1961; 265:721-728.
16. Mondragón-Sánchez R, Garduño-López AL, Murrieta H, Frias-Mendivil M, et al: Intraoperative Abdominal Ultrasonography-guided large volume ethanol injection for Hepatocellular Carcinoma. Gastroenterology 2001; 120(Supp 1):2450.
17. Bartolini F, Gianini A, Napoli P: Hepatocellular carcinoma and cirrhosis. A review of the relative incidence in a 25 year period in the Florence area. Hepatogastroenterology 1984; 31:215-217.
18. Simmoneti RG, Camma C, Fiorello F, Politi F, Pagliaro L: Hepatocellular carcinoma a worldwide problem and major risk factors. Dig Dis Sci 1991; 36:962-972.
19. Chen DS, Kuo GC, Sung JL, et al: Hepatitis C virus infection in an area hyperendemic fro hepatitis B and chronic liver disease. The Taiwan experience. J Infect Dis 1990; 162:817.
20. Akriviadis EA, Llovet JM, Efremidis SC, et al: Hepatocellular carcinoma. Br J Surg 1998; 85:1319-1331.
21. Williams A, Dodd R: The serology of hepatitis C virus in relation to post-transfusion hepatitis. Ann Clin Lab Sci 1990; 20:192-199.
22. Kao JH, Chen DS: Recent research progress in hepatocellular carcinoma. J Formos Med Assoc 2002; 10:239-248.
23. Duraisamy G, Zuridah H, Ariffin MY: Prevalence of hepatitis C virus antibodies in blood donors in Malaysia. Med J Malaysia 1993; 48:313-316.
24. Kuhnl P, Seidl S, Satngel W, Beyer J, Sibrowski W, Flik J: Antibody to hepatitis C virus in German blood donors. Lancet 1989; 11:324-328.
25. Chung HT, Kit JS, Fong AS: Prevention of post-transfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg. Hepatology 1993; 18:1045-1049.
26. Bruix J, Barrera JM, Calvet X, et al: Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrosis. Lancet 1989; 2:1004-1006.
27. Colombo M, Kuo G, Choo Q-L, et al: Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2:1006-1008.
28. Yu MC, Tong AJ, Cousaget P, et al: Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12:671-675.
29. Hernández-Pérez RE, Frías-Salcedo JA, Del Angel-Guevara O: Seroprevalencia de anticuerpos contra el virus de la hepatitis C en donadores de sangre del Hospital Central Militar. Salud Pública Mex 1994; 36:538-540.
30. Suoto-Meriño CA, Simón-Domínguez J, Pulido-Priego MA, y cols: Prevalencia de marcadores para hepatitis A, B y C en un hospital de Mexico. Salud Pública Mex 1994; 36:257-262.
31. Vento S, Cainelli F: Does hepatitis C virus cause severe liver disease only in people who drink alcohol? Lancet Infect Dis 2002; 2:303-309.
32. Lauret E, Rodriguez M, Gonzalez S, Linares A, Lopez-Vazquez A, Martinez-Borra J, Rodrigo L, Lopez-Larrea C: HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma. Am J Gastroenterol 2002; 97:1016-1021.
33. Sarbah S, Younoss Z: Hepatitis C: An Update of Silent Epidemic. J Clin Gastroenterol 2000; 30:125-143.
34. El-Serag HB: Epidemiology of hepatocellular carcinoma. Clin Liv Dis 2001; 5:87-107.
35. Nishtoka K, Watanabe J, Furuta S, et al: A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67:429-433.
36. Donato F, Tagger A, Gelatti U, Parrinello G, et al: Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002:15; 155:323-331.
37. Yamanaka T, Shiraki K, Nakazaawa S, Okano H, et al: Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis. Anticancer Res 2001; 21:2937-2940.
38. Donato MF, Arosio E, Del Ninno E, Ronchi G, et al: High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology 2001; 34:523-528.
39. Sherlock S: Needle biopsy of the liver: A review. J Clin Pathol 1962; 15:291.
40. Kubo S, Tamori A, Ohba K, Shuto T, Yamamoto T, Tanaka H, Nishiguchi S, Wakasa K, Hirohashi K, Kinoshita H: Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis. Dig Dis Sci 2001; 46:2408-2414.
41. Benvegnu L, Alberti A: Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis. Antiviral Res 2001; 52:199-207.
42. Bismuth H, housin D, Ornowski J, Meriggi F: Liver resection in cirrhotic patients: a western experience. World J Surg 1986; 10:311-317
43. Ringe B, Pichlmayr R, Wittekind C, Tush G: Surgical tratment of hepatocellular carcinoma: experience with liver resecction and transplatation in 198 patients. World J Surg 1991; 15:270.